Literature DB >> 10430935

High expression of a specific T-cell receptor gamma transcript in epithelial cells of the prostate.

M Essand1, G Vasmatzis, U Brinkmann, P Duray, B Lee, I Pastan.   

Abstract

We have identified expression of T-cell receptor gamma chain (TCRgamma) mRNA in human prostate and have shown that it originates from epithelial cells of the prostate and not from infiltrating T-lymphocytes. In contrast, the T-cell receptor delta chain (TCRdelta) gene is silent in human prostate. The major TCRgamma transcript in prostate has a different size than the transcript expressed in thymus, spleen, and blood leukocytes. It is expressed in normal prostate epithelium, adenocarcinoma of the prostate, and the prostatic adenocarcinoma cell line LNCaP. The RNA originates from an unrearranged TCRgamma locus, and it is initiated within the intronic sequence directly upstream of the Jgamma1.2 gene segment. The prostate-specific TCRgamma transcript consists of the Jgamma1.2 and Cgamma1 gene segments, and it has an untranslated sequence including a polyadenylation signal and poly(A) sequence at the 3'end. The finding that prostate epithelial cells express a high level of a transcript from a gene that was thought to by exclusively expressed by T-lymphocytes is highly unexpected.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430935      PMCID: PMC17772          DOI: 10.1073/pnas.96.16.9287

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

Review 1.  Genetic organization of the human T-cell receptor gamma and delta loci.

Authors:  M P Lefranc; T H Rabbitts
Journal:  Res Immunol       Date:  1990-09

2.  Laser capture microdissection.

Authors:  M R Emmert-Buck; R F Bonner; P D Smith; R F Chuaqui; Z Zhuang; S R Goldstein; R A Weiss; L A Liotta
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

Review 3.  Accessibility control of antigen-receptor variable-region gene assembly: role of cis-acting elements.

Authors:  B P Sleckman; J R Gorman; F W Alt
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

4.  Pre-thymic transcription of TCR genes by adult murine bone marrow cells.

Authors:  T G Wang; L Lybarger; R Soloff; D Dempsey; R Chervenak
Journal:  Mol Immunol       Date:  1996-08       Impact factor: 4.407

5.  Germ-line transcription of the T cell receptor delta gene in mouse hematopoietic cell lines.

Authors:  M Shimamura; S Ohta
Journal:  Eur J Immunol       Date:  1995-06       Impact factor: 5.532

6.  Structurally divergent human T cell receptor gamma proteins encoded by distinct C gamma genes.

Authors:  M S Krangel; H Band; S Hata; J McLean; M B Brenner
Journal:  Science       Date:  1987-07-03       Impact factor: 47.728

7.  Localization of the human T-cell receptor gamma locus (TCRG) to 7p14----p15 by in situ hybridization.

Authors:  M Bensmana; M G Mattei; M P Lefranc
Journal:  Cytogenet Cell Genet       Date:  1991

8.  Molecular mapping of the human T cell receptor gamma (TRG) genes and linkage of the variable and constant regions.

Authors:  M P Lefranc; P Chuchana; P Dariavach; C Nguyen; S Huck; F Brockly; B Jordan; G Lefranc
Journal:  Eur J Immunol       Date:  1989-06       Impact factor: 5.532

9.  Ordered rearrangement of variable region genes of the T cell receptor gamma locus correlates with transcription of the unrearranged genes.

Authors:  J P Goldman; D M Spencer; D H Raulet
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

10.  Temporal and lineage-specific control of T cell receptor alpha/delta gene rearrangement by T cell receptor alpha and delta enhancers.

Authors:  P Lauzurica; M S Krangel
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

View more
  25 in total

Review 1.  Molecular profiling of clinical tissues specimens: feasibility and applications.

Authors:  M R Emmert-Buck; R L Strausberg; D B Krizman; M F Bonaldo; R F Bonner; D G Bostwick; M R Brown; K H Buetow; R F Chuaqui; K A Cole; P H Duray; C R Englert; J W Gillespie; S Greenhut; L Grouse; L W Hillier; K S Katz; R D Klausner; V Kuznetzov; A E Lash; G Lennon; W M Linehan; L A Liotta; M A Marra; P J Munson; D K Ornstein; V V Prabhu; C Prang; G D Schuler; M B Soares; C M Tolstoshev; C D Vocke; R H Waterston
Journal:  J Mol Diagn       Date:  2000-05       Impact factor: 5.568

Review 2.  Molecular profiling of clinical tissue specimens: feasibility and applications.

Authors:  M R Emmert-Buck; R L Strausberg; D B Krizman; M F Bonaldo; R F Bonner; D G Bostwick; M R Brown; K H Buetow; R F Chuaqui; K A Cole; P H Duray; C R Englert; J W Gillespie; S Greenhut; L Grouse; L W Hillier; K S Katz; R D Klausner; V Kuznetzov; A E Lash; G Lennon; W M Linehan; L A Liotta; M A Marra; P J Munson; D K Ornstein; V V Prabhu; C Prange; G D Schuler; M B Soares; C M Tolstoshev; C D Vocke; R H Waterston
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

3.  Characterization of prostate cell types by CD cell surface molecules.

Authors:  Alvin Y Liu; Lawrence D True
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

4.  TARP: a nuclear protein expressed in prostate and breast cancer cells derived from an alternate reading frame of the T cell receptor gamma chain locus.

Authors:  C D Wolfgang; M Essand; J J Vincent; B Lee; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

Review 5.  Strategies to use immune modulators in therapeutic vaccines against cancer.

Authors:  Jay A Berzofsky; Masaki Terabe; Lauren V Wood
Journal:  Semin Oncol       Date:  2012-06       Impact factor: 4.929

6.  Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays.

Authors:  Marie Tosolini; Frédéric Pont; Mary Poupot; François Vergez; Marie-Laure Nicolau-Travers; David Vermijlen; Jean-Emmanuel Sarry; Francesco Dieli; Jean-Jacques Fournié
Journal:  Oncoimmunology       Date:  2017-02-06       Impact factor: 8.110

7.  T cells engineered with a T cell receptor against the prostate antigen TARP specifically kill HLA-A2+ prostate and breast cancer cells.

Authors:  Victoria Hillerdal; Berith Nilsson; Björn Carlsson; Fredrik Eriksson; Magnus Essand
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-10       Impact factor: 11.205

8.  High expression of a cytokeratin-associated protein in many cancers.

Authors:  Kristi A Egland; Xiu Fen Liu; Stephen Squires; Satoshi Nagata; Yan-Gao Man; Tapan K Bera; Masanori Onda; James J Vincent; Robert L Strausberg; Byungkook Lee; Ira Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

9.  Discovery of the breast cancer gene BASE using a molecular approach to enrich for genes encoding membrane and secreted proteins.

Authors:  Kristi A Egland; James J Vincent; Robert Strausberg; Byungkook Lee; Ira Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

10.  TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancer.

Authors:  Lauren V Wood; Antonio Fojo; Brenda D Roberson; Meghan S B Hughes; William Dahut; James L Gulley; Ravi A Madan; Philip M Arlen; Marianna Sabatino; David F Stroncek; Luciano Castiello; Jane B Trepel; Min-Jung Lee; Howard L Parnes; Seth M Steinberg; Masaki Terabe; Julia Wilkerson; Ira Pastan; Jay A Berzofsky
Journal:  Oncoimmunology       Date:  2016-07-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.